Cargando…

Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity

Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Herpers, Bram, Wink, Steven, Fredriksson, Lisa, Di, Zi, Hendriks, Giel, Vrieling, Harry, de Bont, Hans, van de Water, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830895/
https://www.ncbi.nlm.nih.gov/pubmed/26026609
http://dx.doi.org/10.1007/s00204-015-1536-3
_version_ 1782426970242416640
author Herpers, Bram
Wink, Steven
Fredriksson, Lisa
Di, Zi
Hendriks, Giel
Vrieling, Harry
de Bont, Hans
van de Water, Bob
author_facet Herpers, Bram
Wink, Steven
Fredriksson, Lisa
Di, Zi
Hendriks, Giel
Vrieling, Harry
de Bont, Hans
van de Water, Bob
author_sort Herpers, Bram
collection PubMed
description Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and NF-κB, respectively. Here, we systematically investigated Nrf2 and NF-κB signaling upon DILI-related drug exposure. Transcriptomics analyses of 90 DILI compounds in primary human hepatocytes revealed that a strong Nrf2 activation is associated with a suppression of endogenous NF-κB activity. These responses were translated into quantitative high-content live-cell imaging of induction of a selective Nrf2 target, GFP-tagged Srxn1, and the altered nuclear translocation dynamics of a subunit of NF-κB, GFP-tagged p65, upon TNFR signaling induced by TNFα using HepG2 cells. Strong activation of GFP-Srxn1 expression by DILI compounds typically correlated with suppression of NF-κB nuclear translocation, yet reversely, activation of NF-κB by TNFα did not affect the Nrf2 response. DILI compounds that provided strong Nrf2 activation, including diclofenac, carbamazepine and ketoconazole, sensitized toward TNFα-mediated cytotoxicity. This was related to an adaptive primary protective response of Nrf2, since loss of Nrf2 enhanced this cytotoxic synergy with TNFα, while KEAP1 downregulation was cytoprotective. These data indicate that both Nrf2 and NF-κB signaling may be pivotal in the regulation of DILI. We propose that the NF-κB-inhibiting effects that coincide with a strong Nrf2 stress response likely sensitize liver cells to pro-apoptotic signaling cascades induced by intrinsic cytotoxic pro-inflammatory cytokines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1536-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4830895
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48308952016-04-25 Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity Herpers, Bram Wink, Steven Fredriksson, Lisa Di, Zi Hendriks, Giel Vrieling, Harry de Bont, Hans van de Water, Bob Arch Toxicol Organ Toxicity and Mechanisms Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and NF-κB, respectively. Here, we systematically investigated Nrf2 and NF-κB signaling upon DILI-related drug exposure. Transcriptomics analyses of 90 DILI compounds in primary human hepatocytes revealed that a strong Nrf2 activation is associated with a suppression of endogenous NF-κB activity. These responses were translated into quantitative high-content live-cell imaging of induction of a selective Nrf2 target, GFP-tagged Srxn1, and the altered nuclear translocation dynamics of a subunit of NF-κB, GFP-tagged p65, upon TNFR signaling induced by TNFα using HepG2 cells. Strong activation of GFP-Srxn1 expression by DILI compounds typically correlated with suppression of NF-κB nuclear translocation, yet reversely, activation of NF-κB by TNFα did not affect the Nrf2 response. DILI compounds that provided strong Nrf2 activation, including diclofenac, carbamazepine and ketoconazole, sensitized toward TNFα-mediated cytotoxicity. This was related to an adaptive primary protective response of Nrf2, since loss of Nrf2 enhanced this cytotoxic synergy with TNFα, while KEAP1 downregulation was cytoprotective. These data indicate that both Nrf2 and NF-κB signaling may be pivotal in the regulation of DILI. We propose that the NF-κB-inhibiting effects that coincide with a strong Nrf2 stress response likely sensitize liver cells to pro-apoptotic signaling cascades induced by intrinsic cytotoxic pro-inflammatory cytokines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1536-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-05-31 2016 /pmc/articles/PMC4830895/ /pubmed/26026609 http://dx.doi.org/10.1007/s00204-015-1536-3 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Organ Toxicity and Mechanisms
Herpers, Bram
Wink, Steven
Fredriksson, Lisa
Di, Zi
Hendriks, Giel
Vrieling, Harry
de Bont, Hans
van de Water, Bob
Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title_full Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title_fullStr Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title_full_unstemmed Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title_short Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
title_sort activation of the nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of nf-κb activation and sensitizes toward tnfα-induced cytotoxicity
topic Organ Toxicity and Mechanisms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830895/
https://www.ncbi.nlm.nih.gov/pubmed/26026609
http://dx.doi.org/10.1007/s00204-015-1536-3
work_keys_str_mv AT herpersbram activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT winksteven activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT fredrikssonlisa activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT dizi activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT hendriksgiel activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT vrielingharry activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT debonthans activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity
AT vandewaterbob activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity